The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Morozova M.M.

Petrovsky Russian Research Center of Surgery

Ivanova E.I.

National Medical Research Center for Therapy and Preventive Medicine

Chardarov N.K.

Petrovsky Russian Research Center of Surgery

Dolzhansky O.V.

Petrovsky Russian Scientific Center of Surgery

Shatveryan G.A.

Petrovsky Russian Research Center of Surgery

Kamalov Yu.R.

Petrovsky Russian Research Center of Surgery

Multiple hepatocellular adenomas and renal cell carcinoma associated with anabolic androgenic steroids

Authors:

Morozova M.M., Ivanova E.I., Chardarov N.K., Dolzhansky O.V., Shatveryan G.A., Kamalov Yu.R.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2021;(10): 105‑109

Read: 6592 times


To cite this article:

Morozova MM, Ivanova EI, Chardarov NK, Dolzhansky OV, Shatveryan GA, Kamalov YuR. Multiple hepatocellular adenomas and renal cell carcinoma associated with anabolic androgenic steroids. Pirogov Russian Journal of Surgery. 2021;(10):105‑109. (In Russ.)
https://doi.org/10.17116/hirurgia2021101105

References:

  1. Socas L, Zumbado ML, Pérez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: A report of two cases and a review of the literature. British Journal of Sports Medicine. 2005;39(5):e27.  https://doi.org/10.1136/bjsm.2004.013599
  2. Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrology. 2019;198.  https://doi.org/10.1186/s12882-019-1384-0
  3. Johnson FL, Lerner KG, Siegel M et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. The Lancet. 1972;2(7790):1273-1276. https://doi.org/10.1016/s0140-6736(72)92649-9
  4. Velazquez I, Alter BP. Androgens and Liver Tumors: Fanconi’s Anemia and non-Fanconi’s Conditions. American Journal of Hematology. 2004;3(77):257-267.  https://doi.org/10.1002/ajh.20183
  5. Solbach P, Potthoff A, Raatschen HJ, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterology. 2015;20:60.  https://doi.org/10.1186/s12876-015-0288-0
  6. Hardt A, Stippel D, Odenthal M, et al. Development of Hepatocellular Carcinoma Associated with Anabolic Androgenic Steroid Abuse in a Young Bodybuilder: A Case Report. Case Reports in Pathology. 2012;5.  https://doi.org/10.1155/2012/195607
  7. Gorayski P, Thompson CH, Subhash HS et al. Hepatocellular carcinoma associated with recreational anabolic steroid use. British Journal of Sports Medicine. 2008;42:74-75.  https://doi.org/10.1136/bjsm.2007.03932
  8. Bryden AA, Rothwell PN, O’Reilly PH. Anabolic steroid abuse and renal-cell carcinoma. The Lancet. 1995;346(8985):1306-1307. https://doi.org/10.1016/s0140-6736(95)91915-5
  9. Martorana G, Concetti S, Manferrari F, et al. Anabolic steroid abuse and renal cell carcinoma. The Journal of Urology. 1999;162(6):2089. https://doi.org/10.1016/S0022-5347(05)68110-4
  10. Prat J, Gray GF, Stolley PD. Wilms Tumor in an Adult Associated With Androgen Abuse. The Journal of the American Medical Association. 1977;237(21):2322-2323. https://doi.org/10.1001/jama.1977.03270480062023
  11. Roberts JT, Essenhigh DM. Adenocarcinoma of the prostate in a 40-year- old bodybuilder. The Lancet. 1986;2:742.  https://doi.org/10.1016/s0140-6736(86)90251-5
  12. Paner GP, Amin MB. Alvarado-Cabrero I, et al. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Furman nuclear grade. The American Journal of Surgical Pathology. 2010;34(9):1233-1240. https://doi.org/10.1097/PAS.0b013e3181e96f2a
  13. Pinto F, Sacco E, Volpe A, et al. Doping And Urologic Tumors. Urologia. 2010;28:77(2):92-99.  https://doi.org/10.1177/039156031007700205
  14. Sempoux C, Balabaud C, Bioulac-Sage P. Malignant transformation of hepatocellular adenoma. Hepatic Oncology. 2014;1(4):421-431.  https://doi.org/10.2217/hep.14.14
  15. Garcia-Buitrago MT. Beta-catenin Staining of Hepatocellular Adenomas. Gastroenterology and Hepatology. 2017;13(12):740-743. 
  16. Haring MPD, Gouw ASH, de Haas RJ et al. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: a retrospective cohort study. Liver International. 2019;39:905-913.  https://doi.org/10.1111/liv.14074

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.